Use of non-subtype B gag proteins for lentiviral packaging

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9752160
APP PUB NO 20140234908A1
SERIAL NO

14346961

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention encompasses a lentiviral packaging vector comprising a non-subtype B gag-pol sequence, particularly a subtype D gag-pol sequence. The invention further encompasses methods for making and using these vectors. The invention further encompasses lentiviral vector particles comprising HIV-1 non-subtype B Gag and/or Pol proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT PASTEURPARIS FRANCE PARIS PARIS
THERAVECTYSBATIMENT PASTEUR BIOTOP 28 RUE DU DOCTEUR ROUX PARIS F-75015

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bauche, Cecile Paris, FR 16 31
Charneau, Pierre Paris, FR 52 379
Tran, Thi-Lan Jouy en Josas, FR 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00